Perlmutter Cancer Center at NYU Langone Health names new neuro-oncology chief
Click Here to Manage Email Alerts
Alexandra Miller, MD, PhD, has been named the new chief of the division of neuro-oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center.
Miller, who assumed her new roles on Jan. 29, is a neurologist and neuro-oncologist specializing in the treatment of primary brain tumors. She previously served as the chief of neurology resident and chief neuro-oncology fellow at Memorial Sloan Kettering Cancer Center, according to a press release.
Miller is an active member of American Academy of Neurology, Society for Neuro-Oncology, ASCO, and American Association for Cancer Research. She has authored and co-authored research papers published in Nature, Neuro Oncology, Neurology and The Journal of Neuroscience.
“I’m honored to join NYU Langone’s Perlmutter Cancer Center, which is at the forefront of cancer care and research,” Miller said in the release. “I am looking forward to working with the extensive network of diagnostic, surgical and rehabilitative specialists to develop our programs even further.”
As chief of the division of neuro-oncology, Miller will continue to build upon the team of researchers and clinicians, as well as lead and mentor junior faculty to improve outcomes and access for patients undergoing treatment for brain tumors. As co-director of the Brain and Spine Tumor Center, she will collaborate with other co-directors, and the wider team of neuro-oncologists, neurologists, neurosurgeons, neuroradiologists and radiation oncologists, to expand upon the multidisciplinary clinical program around primary and metastatic brain tumors, according to the release.
“We are thrilled to welcome Dr. Miller, who is a renowned expert in brain tumor research,” Alec Kimmelman, MD, PhD, director of Perlmutter Cancer Center, said in the release. “Her leadership and experience in both the clinical and research missions will allow us to deliver comprehensive care and offer the latest treatment advances to our patients.”
Click Here to Manage Email Alerts